NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I don’t know that to be the case. Many of us advocated for people to average down when it was in the teens and low .20 range especially. It is very easy and in fact cheap to lower one’s price for many fewer shares when you bought at a very high price and also possible to grow one’s investment dollars in a portfolio when one harvests losses against gains and rebalances.

People should not invest in segments like this if they can’t handle the volatility. Volatility is clearly a huge part of the ride and profit, but it’s also a huge part that distinguishes investors. Most people should obviously be in indexes and even then a lot of smart people who have not prepared themselves can compound losses by buying high, when there is market euphoria and FOMO and then selling in fear during market crashes like 2008 and even during COVID.

This is part of markets and understanding one’s risk tolerances. For those needing cash, buying at .17 and .20 and selling well above $2.00 would likely have well compensated people for their losses. If they decided to hold while shorts squeezed us a second round, which was predictable especially waiting for approval and even after approvals, if you watch the sector, then those investors were making a choice to hold as long as it takes to get the full benefit. They obviously could have traded. I held onto my shares when I could have sold at huge profit at that $2.51 and above $2.00 range myself. Might not have been the best move, but as I said. I am well positioned in terms of average price, and I do make it a point to rebalance by selling shares that were at higher prices early on against gains in other stocks, which allowed me to net, keep the gain and rebalance. Generally I bought more NWBO after the relevant period to an ensure I got the full tax benefit and also got the best price. Virtually all of my shares are .20 and below. With a good chunk at .17.

People lose money buying Apple too. But during long stretches in this stock, the 5 year and even 2 year period for holding showed very good gains not easily found in many other investments, though we have had some fantastic, historical gains in certain technology stocks and that will likely continue. Technology is easier in some ways, because you have almost instant satisfaction once companies are well established and they create hit products. However, fortunes can turn quickly, or seem to turn. That might last or just be a passing moment of market anxiety and fear.

The fact is, this team steered this to a successful completion of a very difficult trial, set-up so because of ethical and regulatory concerns at the beginning of the immunotherapy journey. But most reliable experts seem to agree this is likely to be approved and to be shown to ultimately be a very meaningful breakthrough in oncology. I expect there will be many others as large resources are being channeled into oncology research and immunotherapies. But this treatment has one big advantage, the end product vaccine is not a batch of highly modified cells that will react in unexpected ways like killing patients or creating new cancers, like Car-T, which enjoyed a huge bubble.

For simplicity’s sake in the averaging down, we could take any number investment or dollar amount, but let’s say someone bought 1,000 shares at $12, costing $12,000. And they watched the stock decline to .20. Let’s say they took another $12,000, then and purchased shares for the full amount possible. That would be 60,000 shares. Now they have 72,000 shares. If they sold at .3333 per share they’d be breaking even. At $2.51, they had $180,720. Today they would have $41,148, but in September they could have sold for $75,600.

Not underwater and with lots of potential excitement ahead. But anyone buying these stocks knows and has to know whether it is NWBO or it was REGN during their very long journey to validation, a total loss is always possible. People buy these stocks for the volatility and opportunity that they provide upon success, not on average during the day to day swings. Though clearly there are some traders who do trade in and out and we know that some of them here have explained that they think this stock has been volatile like clockwork and that was easy for them to do and they did so quite profitably, ultimately some indicating it allowed them to really grow their stake. Some of those persons today would apparently be loathe to admit their claims over the years, to that effect, but I was here and see those posts. No foul. That is what they did. But those who do so while changing the narrative they amplify on each swing trade, those folks, I think, play dirty. Trading is fine, manipulation is not.